Less Ads, More Data, More Tools Register for FREE

Pin to quick picksComputacenter Regulatory News (CCC)

Share Price Information for Computacenter (CCC)

Share Price is delayed by 15 minutes
Get Live Data
4,176.00    86.00 (2.10%)
Bid:
4,152.00
Ask:
4,158.00
Spread: 6.00 (0.145%)
Market Cap: £4.38b
CCC Live PriceLast checked at - London Stock Exchange

Intraday Computacenter Share Chart

Director/PDMR Shareholding

22 Mar 2024 16:00

RNS Number : 0256I
Computacenter PLC
22 March 2024

Computacenter plc

Incorporated in England

Registration number: 03110569

LEI: 549300XSXUZ1I19DB105

ISIN: GB00BV9FP302

Computacenter plc

(the 'Company')

The following notifications are made under Article 19 of the Market Abuse Regulation ('MAR') relating to certain transactions in the shares of the Company by Directors of the Company, Persons Discharging Managerial Responsibilities ('PDMR') of the Company and Persons Closely Associated ('PCA') with the Directors and PDMRs.

Vesting of Awards, Exercise of Options and Subsequent Sale of Shares

Computacenter Performance Share Plan 2005

The Company announces that on 21 March 2024, in accordance with the rules of the PSP, the nil-cost option award over Ordinary Shares, which was granted on 22 March 2021, vested for the following Director. Vesting of the PSP Award was subject to the achievement of performance conditions over a three year period.

DIRECTOR

Number of options awarded

% Award

Vested1

Number of options vested

Number of options lapsed

Number of options exercised

Number of options held

Mr M J Norris (Director)

51,678

90.86%

46,954

4,724

-

46,954

1 Awards granted under the PSP Plan vest subject to the satisfaction of performance conditions at the end of a three year period. The level of vesting for PSP Awards granted in 2021 was 90.86% for the PSP Enhanced Plan. The PSP Award vested is subject to a two year holding period before they are released to the Director.

Computacenter 2017 Deferred Bonus Plan

The Company announces that on 21 March 2024, the following conditional award over Ordinary Shares vested for the Director below. This followed, in accordance with the rules of the Computacenter 2017 Deferred Bonus Plan, the Company vesting tranches of the related conditional 2021 Bonus Award, which was granted on 21 March 2022, over Ordinary Shares. Vesting of this tranche of the 2021 Bonus Award was subject to the completion of a two-year holding period. Further, certain of the Ordinary Shares, resulting from the vesting of the award, were sold for 2714 pence each.

DIRECTOR

Number of shares vested2

Number of shares sold

Number of shares retained

Mr M J Norris (Director)

7,527

7,527

-

2 On 21 March 2024, the Director listed above became entitled to ordinary shares of 75/9 pence each in the capital of the Company, as a result of an Award vesting under the DBP. Awards granted under the DBP Plan vest in two tranches with one-half of the deferred shares from the Bonus Awards vesting after one year and the remaining deferred shares from the Bonus Awards vesting after two years. The shares vesting above relate to the second tranche of the 2021 Bonus Award made on 21 March 2022. The shares were released to the Director on 21 March 2024 when the transaction noted above took place. The vesting amount included 441 shares, awarded as dividend equivalent shares equal in value to dividends that would have been paid on the shares in respect of which the award vests in respect of dividend record dates during the period between the grant date and the vesting date.

The relevant FCA notifications are set out below.

PDMR/PCA FCA Transaction Notification

1.

Details of Director/Person Discharging Managerial Responsibilities

Name

Michael John Norris

2.

Reason for the notification

2(a)

Position/Status

Chief Executive Officer

2(b)

Initial Notification/

Amendment

Initial Notification

3.

Details of the issuer

3(a)

Name

Computacenter plc

3(b)

LEI

549300XSXUZ1I19DB105

4.

Details of the transaction(s): Section to be repeated for (i) each type of instrument, (ii) each type of transaction, (iii) each date and (iv) each place where transaction(s) have been conducted

4(a)

Description of the financial instrument

Ordinary shares of 7 5/9 pence in Computacenter plc ('Ordinary Shares')

ISIN: GB00BV9FP302

4(b)

Nature of Transaction

Ordinary Shares acquired following the vesting of a conditional award, made on 21 March 2022, under the Computacenter 2017 Deferred Bonus Plan (the '2021 Bonus Award'). There is no price payable on the grant or exercise of the 2021 Bonus Award. Vesting of this tranche of the 2021 Bonus Award was subject to the completion of a two year holding period.

4(c)

Price(s) and Volume(s)

Price(s) (in GBP)

Volume(s)

nil

7,086

4(d)

Aggregated Information

Aggregated Volume and Price

nil

7,086

4(e)

Date of the transaction

21-03-2024

4(f)

Place of the transaction

Outside of a trading venue. The Ordinary Shares for the above-mentioned exercise were satisfied out of those held by the 2011 Computacenter Employee Benefit Trust.

4.

Details of the transaction(s): Section to be repeated for (i) each type of instrument, (ii) each type of transaction, (iii) each date and (iv) each place where transaction(s) have been conducted

4(a)

Description of the financial instrument

Ordinary shares of 7 5/9 pence in Computacenter plc ('Ordinary Shares')

ISIN: GB00BV9FP302

4(b)

Nature of Transaction

Ordinary Shares acquired as dividend equivalents related to the grant and vesting of a conditional award, made on 21 March 2022, under the Computacenter 2017 Deferred Bonus Plan (the 'Bonus Award Dividend Equivalents'). There is no price payable on the acquisition of the Bonus Award Dividend Equivalents.

4(c)

Price(s) and Volume(s)

Price(s) (in GBP)

Volume(s)

nil

441

4(d)

Aggregated Information

Aggregated Volume and Price

nil

441

4(e)

Date of the transaction

21-03-2024

4(f)

Place of the transaction

Outside of a trading venue. The Ordinary Shares for the above-mentioned exercise were satisfied out of those held by the 2011 Computacenter Employee Benefit Trust.

4.

Details of the transaction(s): Section to be repeated for (i) each type of instrument, (ii) each type of transaction, (iii) each date and (iv) each place where transaction(s) have been conducted

4(a)

Description of the financial instrument

Ordinary shares of 7 5/9 pence in Computacenter plc ('Ordinary Shares')

ISIN: GB00BV9FP302

4(b)

Nature of Transaction

Sale of Ordinary Shares. Sold all 7,527 Shares from the conditional award vested, and dividend equivalent shares acquired, under the Computacenter 2017 Deferred Bonus Plan.

4(c)

Price(s) and Volume(s)

Price(s) (in GBP)

Volume(s)

27.14

7,527

4(d)

Aggregated Information

Aggregated Volume and Price

27.14

7,527

4(e)

Date of the transaction

21-03-2024

4(f)

Place of the transaction

XLON

4.

Details of the transaction(s): Section to be repeated for (i) each type of instrument, (ii) each type of transaction, (iii) each date and (iv) each place where transaction(s) have been conducted

4(a)

Description of the financial instrument

Ordinary shares of 7 5/9 pence in Computacenter plc ('Ordinary Shares')

ISIN: GB00BV9FP302

4(b)

Nature of Transaction

Ordinary Shares acquired following exercise of a nil-cost option awarded under the Computacenter Performance Share Plan 2005 (the 'PSP Award'). There was no price payable on the grant or exercise of the PSP Award. Vesting of the PSP Award was subject to the achievement of a performance condition over a three year period and released after a two year holding period.

4(c)

Price(s) and Volume(s)

Price(s) (in GBP)

Volume(s)

Nil

90,604

4(d)

Aggregated Information

Aggregated Volume and Price

Nil

90,604

4(e)

Date of the transaction

21-03-2024

4(f)

Place of the transaction

Outside of a trading venue. The Ordinary Shares for the above-mentioned exercise were satisfied out of those held by the 2011 Computacenter Employee Benefit Trust.

4.

Details of the transaction(s): Section to be repeated for (i) each type of instrument, (ii) each type of transaction, (iii) each date and (iv) each place where transaction(s) have been conducted

4(a)

Description of the financial instrument

Ordinary shares of 7 5/9 pence in Computacenter plc ('Ordinary Shares')

ISIN: GB00BV9FP302

4(b)

Nature of Transaction

Sale of Ordinary Shares. Sold all 90,604 shares acquired following the exercise of a nil-cost option vested under the Computacenter Performance Share Plan 2005.

4(c)

Price(s) and Volume(s)

Price(s) (in GBP)

Volume(s)

27.017888

90,604

4(d)

Aggregated Information

Aggregated Volume and Price

27.017888

90,604

4(e)

Date of the transaction

21-03-2024

4(f)

Place of the transaction

XLON

Enquiries:

Name:

Simon Pereira

Company Secretary

Address:

Computacenter plc

Hatfield Avenue

Hatfield

Hertfordshire

AL10 9TW

Telephone:

+44 (0) 7385 514 715

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
DSHEASDAADKLEFA
Date   Source Headline
2nd Nov 20227:00 amRNSDirectorate Change
28th Oct 20227:00 amRNSQ3 2022 Trading Update
20th Oct 202210:30 amRNSDirectorate Change
27th Sep 202212:00 pmRNSHolding(s) in Company
22nd Sep 202210:30 amRNSDirector/PDMR Shareholding
12th Sep 202212:00 pmRNSDirector/PDMR Shareholding
9th Sep 20227:00 amRNSHalf-year Report
5th Aug 20229:30 amRNSBlock listing Interim Review
13th Jul 20227:00 amRNSAcquisition
19th May 20221:30 pmRNSResult of AGM
9th May 20225:30 pmRNSHolding(s) in Company
29th Apr 20227:00 amRNSQ1 2022 Trading Update
27th Apr 20229:03 amRNSCarbon Neutral Announcement
13th Apr 202212:15 pmRNS2021 Annual Financial Report & Notice of 2022 AGM
23rd Mar 20224:45 pmRNSDirector/PDMR Shareholding
16th Mar 20227:00 amRNSFinal Results 2021
7th Feb 20229:49 amRNSBlock listing Interim Review
24th Jan 20227:00 amRNSPre-Close Trading Statement
12th Jan 20229:45 amRNSHolding(s) in Company
14th Dec 20214:45 pmRNSHolding(s) in Company
13th Dec 20215:00 pmRNSHolding(s) in Company
10th Dec 20212:00 pmRNSCompany Secretary Change
2nd Dec 20212:45 pmRNSDirector/PDMR Shareholding
15th Nov 202112:15 pmRNSDirector/PDMR Shareholding
29th Oct 20217:00 amRNSQ3 2021 Trading Update
30th Sep 202112:00 pmRNSDirectorate Change
15th Sep 20214:25 pmRNSDirector/PDMR Shareholding
9th Sep 20217:00 amRNSHalf-year Report
31st Aug 20217:00 amRNSTrading Statement
12th Aug 202112:00 pmRNSDirector Declaration
6th Aug 202111:15 amRNSBlock listing Interim Review
21st Jul 20217:00 amRNSTrading Statement
20th May 20211:00 pmRNSResult of AGM
30th Apr 20217:00 amRNSDirector/PDMR Shareholding
29th Apr 20217:00 amRNSQ1 2021 Trading Update
20th Apr 20217:00 amRNS2020 Annual Report & Notice of 2021 AGM
24th Mar 20212:00 pmRNSDirector/PDMR Shareholding
16th Mar 20217:00 amRNSFinal Results 2020
10th Mar 20217:00 amRNSDirectorate Change
5th Feb 20211:18 pmRNSBlock listing Interim Review
25th Jan 202111:45 amRNSDirector/PDMR Shareholding
22nd Jan 20217:00 amRNSPre-Close Trading Statement
4th Jan 20211:00 pmRNSDirector/PDMR Shareholding
10th Dec 20207:00 amRNSTrading Statement
10th Nov 20204:00 pmRNSPDMR/PCA Shareholding
30th Oct 20207:00 amRNSQ3 2020 Trading Update
27th Oct 20209:30 amRNSDirector/PDMR Shareholding
23rd Oct 20205:45 pmRNSApproval of Arrangement Agreement
16th Sep 202012:45 pmRNSDirector/PDMR Shareholding
15th Sep 20201:00 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.